S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Clinical Data on AVEO Oncology’s Ficlatuzumab and Tivozanib to Be Presented at the ESMO 2014 Congress|
|AVEO Oncology Announces Presentation of AV-380 Preclinical Data at 2nd Cancer Cachexia Conference|
|AVEO Oncology Announces Lease Termination and Amendment to Debt Financing Facility|
|AVEO Oncology Announces Results from Phase 2 Clinical Studies of Tivozanib in Patients with Advanced Colorectal and Kidney Cancers Presented at ESMO 2014 Congress|
|AVEO and Biodesix Announce Exploratory Analysis of VeriStrat-Selected Patients with Non-Small Cell Lung Cancer in Phase 2 Study of Ficlatuzumab Presented at ESMO 2014 Congress|
|AVEO Oncology Reports Third Quarter 2014 Financial Results|
|AVEO Enters into Research and Exclusive Option Agreement with Ophthotech for Tivozanib (VEGF inhibitor) for the Treatment of Ocular Diseases|
|BioMed Realty Trust Reports Third Quarter 2014 Financial Results|
|Ophthotech Provides Business Update and Reports Third Quarter 2014 Financial Results|
|UPDATE: Only 4 Teslas have ever been stolen in U.S. (2014/10/11)|
Click above to view more mutual fund data and stats for aveo - AVEO Pharmaceuticals Inc.